Actos Bladder Cancer Lawsuits & Settlements Claims
If you or a loved one has developed bladder cancer or other serious health problems as a result of the use of the popular diabetes drug Actos you may be eligible to file an Actos bladder cancer lawsuit and seek compensation.
Our experienced, aggressive lawyers are now investigating claims from Actos patients who have suffered serious side effects caused by this product. Please contact us as soon as possible to ensure that all of your legal rights are protected.
There may be time limits involved in certain cases and the earlier you contact us the more effectively we can begin pursuing compensation in Actos cases in which eligibility is determined.
Free consultations are being offered to advise families about the legal options that may be available to them in seeking compensation for a death, medical costs, pain and suffering or other expenses that may have been incurred as a result of the use of Actos.
NUMEROUS ACTOS LAWSUITS HAVE BEEN FILED
NEWS: April 8, 2014A New York hardware store manager who developed bladder cancer as a result of long-time treatment for his diabetes with Actos has been awarded more than $9 billion in damages.
The number of patients who have suffered bladder cancer as a result of their use of Actos to treat diabetes has climbed to significant numbers. In fact, there have been so many Actos bladder cancer victims filing lawsuits over health problems they have suffered that the federal court system has coordinated many of them in what is called a multi-district litigation in Louisiana.
The Louisiana multi-district litigation involves common lawsuits that have been filed against Asian pharmaceutical giant Takeda Pharmaceuticals, which developed the medication.
The lawsuits involve claims by diabetes patients who took Actos that Takeda knew of the links between the medication and increased risks of developing bladder cancer but did not take adequate action to warn patients, health care professionals and government regulators.
What is contained in an Actos lawsuit? One plaintiff’s claims are similar to the others in alleging he "was injured as a result of his use of Actos, and therefore seeks damages for pain and suffering, ascertainable economic losses, attorneys’ fees, reimbursement of cost of obtaining Actos, reimbursement for all past, present and future health and medical care costs related to Actos."
The victim also is seeking compensation for his wife who, according to the lawsuit “was deprived of the care, consideration, compassion, consortium and concern” from the victim.
The victim claims that “as a result of the defective nature of Actos” he and other patients who were prescribed the drug suffer from bladder cancer, for which he was hospitalized.
"Defendants concealed and continue to conceal their knowledge of Actos’ unreasonably dangerous risk from Plaintiff, his physicians, other consumers, and the medical community,” according to the lawsuit.
"Specifically, Defendants failed to adequately inform consumers and the prescribing medical community about the risk of bladder cancer associated with more than twelve months of Actos ingestion."
Also named as a defendant in this and other lawsuits in the multi-district litigation is another pharmaceutical giant Eli Lilly, which the plaintiff said collaborated with Takeda "to promote and market Actos."
The victim also claims that “Defendants have yet to adequately inform consumers and the prescribing medical community about the risks of bladder cancer with the use of Actos for more than 12 months.
ACTOS BLADDER CANCER WARNING FROM FDA
The free consultations now being offered to Actos bladder cancer victims can spell out the legal options to seek compensation over side effects involving the devastating link between Actos and bladder cancer raised recently in a warning to health care professionals and patients issued by the U.S. Food and Drug Administration.
In its nationwide announcement, the FDA warned that long-term use of Actos may put patients at increased risk of developing bladder cancer. It is not known how many of the millions of Americans who suffer from Type 2 diabetes and used the medication may have been affected by the FDA’s warning but the medication is a popular one and is widely prescribed by physicians.
These consultations can determine eligibility for victims who may have suffered health problems as outlined in the June 15, 2011 FDA warning which said:
"The U.S. Food and Drug Administration (FDA) is informing the public that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about this risk will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines. The patient Medication Guide for these medicines will also be revised to include information on the risk of bladder cancer."
While the FDA has not banned Actos over this cancer link, in its warning agency officials acknowledge that similar concerns have caused government regulators in France to suspend sales of Actos counterparts in Germany to recommend it not be diagnosed for new patients:
"FDA is also aware of a recent epidemiological study conducted in France which suggests an increased risk of bladder cancer with pioglitazone. Based on the results of this study, France has suspended the use of pioglitazone and Germany has recommended not to start pioglitazone in new patients."
DOCTORS DIRECTED TO USE ACTOS WITH CARE
In its nationwide warning about the link between Actos (pioglitazone) and bladder cancer, the FDA made these recommendations to health care professionals:
To not use pioglitazone in patients with active bladder cancer.
To use pioglitazone with caution in patients with a prior history of bladder cancer. The benefits of blood sugar control with pioglitazone should be weighed against the unknown risks for cancer recurrence.
The FDA also announced it will continue to evaluate data from an ongoing ten-year epidemiological study and will also conduct a comprehensive review of the results from the French study.
The FDA said it will update the public when more information becomes available.
The FDA approved Actos in 1999 as the newest type of medication to treat Type 2 diabetes. The 2011 FDA warning came after agency officials said they analyzed the mid-way results of an ongoing 10-year epidemiological study of Actos side effects. It was during that month that French officials halted sales of Actos and German officials made their announcement of concern.
HOW TO FILE AN ACTOS BLADDER CANCER CLAIM
ur nationwide legal team will make it easy for you to file your Actos bladder cancer claim because of the experience they have in handling cases that are to the one about which you are inquiring. The first step is to take advantage of the free consultations we are offering in order to review your eligibility to file and Actos bladder cancer claim. If you or a loved one has suffered bladder cancer or serious health problems as a result of the use of Actos we urge you to contact us as soon as possible for experienced, aggressive legal representation seeking the compensation you may be due, dependent upon the facts of your case. Keep in mind that there may be legal time limits involved and the facts of each case may differ so it is important that you contact our aggressive legal team as soon as possible in order to preserve all of your legal options in an Actos bladder cancer case.
Actos Lawsuits in these States:
Alabama (AL), Alaska (AK), Arizona (AZ), Arkansas (AR), California (CA), Colorado (CO), Connecticut (CT), Delaware (DE), Florida (FL), Georgia (GA), Hawaii (HI), Idaho (ID), Illinois (IL), Indiana (IN), Iowa (IA), Kansas (KS), Kentucky (KY), Louisiana (LA), Maine (ME), Maryland (MD), Massachusetts (MA), Michigan (MI), Minnesota (MN), Mississippi (MS), Missouri (MO), Montana (MT), Nebraska (NE), Nevada (NV), New Hampshire (NH), New Jersey (NJ), New Mexico (NM), New York (NY), North Carolina (NC), North Dakota (ND), Ohio(OH), Oklahoma (OK), Oregon (OR), Pennsylvania (PA), Rhode Island (RI), South Carolina (SC), South Dakota (SD), Tennessee (TN), Texas (TX), Utah (UT), Vermont (VT), Virginia (VI), Washington (WA), Washington DC (DC), West Virginia (WV), Wisconsin (WI), Wyoming (WY).